A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer (HNC)
Status unconfirmed · Early Phase 1
Conditions studied: Head and Neck Cancer
In brief
This randomized, non-blinded, phase 0/I study will assess the feasibility of conducting a large randomized clinical trial to evaluate the efficacy of the ePVA to improve pain management and HRQoL in HNC. Thirty participants undergoing radiation therapy (RT) (with or without chemotherapy) will be randomized to: 1) ePVA intervention or 2) usual care. The intervention consists of participants completing the ePVA every other week during radiation therapy (RT), then weeks 4, 12, and 24 after end of RT. Automated reports of ePVA data, including pain reports and patient-reports of pain medications, will be sent to providers to inform their clinical decisions.
Key facts
- Study ID
- NCT04502797
- Run by
- New York University
- People needed
- 30
- Starts
- 2020-10-08
- Expected to finish
- 2022-03-15
- Last updated by the study team
- 2021-03-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- To be eligible to participate in this study, an individual must meet all of the following criteria:
- Histologically diagnosed HNC
- Undergoing RT with or without chemotherapy,
- English speaking,
- aged 18 years or older.
You may not qualify if…
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Unable to attend scheduled appointment due to geographical, social or mental reseaons,
- In the opinion of the investigator, is unable or unlikely to comply fully with the study requirements or procedures for any reason (e.g. cognitve or physical impairment).
Where it is running
- NYU Rory Meyers College of Nursing — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.